Christin Carter-Su - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Molecular Biology, Cell Biology, Biochemistry

105 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Carter-Su C, Argetsinger LS, Svezhova NV. 2022 Cannon Lecture: An ode to signal transduction - how the growth hormone pathway revealed insight into height, malignancy and obesity. American Journal of Physiology. Endocrinology and Metabolism. PMID 37672248 DOI: 10.1152/ajpendo.00265.2023  0.369
2019 Flores A, Argetsinger LS, Stadler LKJ, Malaga AE, Vander PB, DeSantis LC, Joe RM, Cline JM, Keogh JM, Henning E, Barroso I, Mendes de Oliveira E, Chandrashekar G, Clutter ES, Hu Y, ... ... Carter-Su C, et al. Crucial Role of the SH2B1 PH Domain for the Control of Energy Balance. Diabetes. PMID 31439647 DOI: 10.2337/Db19-0608  0.305
2017 Joe RM, Flores A, Doche ME, Cline JM, Clutter ES, Vander PB, Riedel H, Argetsinger LS, Carter-Su C. Phosphorylation of the Unique C-terminal Tail of the Alpha Isoform of the Scaffold Protein SH2B1 Controls the Ability of SH2B1alpha to Enhance Nerve Growth Factor Function. Molecular and Cellular Biology. PMID 29229648 DOI: 10.1128/Mcb.00277-17  0.417
2015 Carter-Su C, Schwartz J, Argetsinger LS. Growth hormone signaling pathways. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. PMID 26421979 DOI: 10.1016/J.Ghir.2015.09.002  0.593
2014 Pearce LR, Joe R, Doche ME, Su HW, Keogh JM, Henning E, Argetsinger LS, Bochukova EG, Cline JM, Garg S, Saeed S, Shoelson S, O'Rahilly S, Barroso I, Rui L, ... ... Carter-Su C, et al. Functional characterization of obesity-associated variants involving the α and β isoforms of human SH2B1. Endocrinology. 155: 3219-26. PMID 24971614 DOI: 10.1210/En.2014-1264  0.379
2013 Anderson NM, Javadi M, Berndl E, Berberovic Z, Bailey ML, Huang K, Flenniken AM, Osborne LR, Adamson SL, Rossant J, Carter-Su C, Wang C, McNagny KM, Paulson RF, Minden MD, et al. Enu mutagenesis identifies a novel platelet phenotype in a loss-of-function Jak2 allele. Plos One. 8: e75472. PMID 24086539 DOI: 10.1371/Journal.Pone.0075472  0.339
2013 O'Leary EE, Mazurkiewicz-Muñoz AM, Argetsinger LS, Maures TJ, Huynh HT, Carter-Su C. Identification of steroid-sensitive gene-1/Ccdc80 as a JAK2-binding protein. Molecular Endocrinology (Baltimore, Md.). 27: 619-34. PMID 23449887 DOI: 10.1210/Me.2011-1275  0.777
2013 Su HW, Lanning NJ, Morris DL, Argetsinger LS, Lumeng CN, Carter-Su C. Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motility. Journal of Cell Science. 126: 1733-43. PMID 23444381 DOI: 10.1242/Jcs.113050  0.782
2012 Doche ME, Bochukova EG, Su HW, Pearce LR, Keogh JM, Henning E, Cline JM, Saeed S, Dale A, Cheetham T, Barroso I, Argetsinger LS, O'Rahilly S, Rui L, Carter-Su C, et al. Human SH2B1 mutations are associated with maladaptive behaviors and obesity. The Journal of Clinical Investigation. 122: 4732-6. PMID 23160192 DOI: 10.1172/JCI62696  0.368
2012 Javadi M, Hofstätter E, Stickle N, Beattie BK, Jaster R, Carter-Su C, Barber DL. The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor. The Journal of Biological Chemistry. 287: 26223-34. PMID 22669948 DOI: 10.1074/Jbc.M112.382721  0.404
2012 Ray BN, Kweon HK, Argetsinger LS, Fingar DC, Andrews PC, Carter-Su C. Research resource: identification of novel growth hormone-regulated phosphorylation sites by quantitative phosphoproteomics. Molecular Endocrinology (Baltimore, Md.). 26: 1056-73. PMID 22570334 DOI: 10.1210/Me.2011-1258  0.541
2012 Su H, Jiang L, Carter-Su C, Rui L. Glucose enhances leptin signaling through modulation of AMPK activity. Plos One. 7: e31636. PMID 22359610 DOI: 10.1371/Journal.Pone.0031636  0.422
2011 Lanning NJ, Su HW, Argetsinger LS, Carter-Su C. Identification of SH2B1β as a focal adhesion protein that regulates focal adhesion size and number. Journal of Cell Science. 124: 3095-105. PMID 21878491 DOI: 10.1242/Jcs.081547  0.783
2011 Carter-Su C, Argetsinger LS. JAKs, Stats, and CK2? Blood. 118: 5-6. PMID 21737607 DOI: 10.1182/Blood-2011-05-352542  0.533
2011 Maures TJ, Su HW, Argetsinger LS, Grinstein S, Carter-Su C. Phosphorylation controls a dual-function polybasic nuclear localization sequence in the adapter protein SH2B1β to regulate its cellular function and distribution. Journal of Cell Science. 124: 1542-52. PMID 21486950 DOI: 10.1242/Jcs.078949  0.483
2011 Cui TX, Lin G, LaPensee CR, Calinescu AA, Rathore M, Streeter C, Piwien-Pilipuk G, Lanning N, Jin H, Carter-Su C, Qin ZS, Schwartz J. C/EBPβ mediates growth hormone-regulated expression of multiple target genes. Molecular Endocrinology (Baltimore, Md.). 25: 681-93. PMID 21292824 DOI: 10.1210/Me.2010-0232  0.76
2010 Argetsinger LS, Stuckey JA, Robertson SA, Koleva RI, Cline JM, Marto JA, Myers MG, Carter-Su C. Tyrosines 868, 966, and 972 in the kinase domain of JAK2 are autophosphorylated and required for maximal JAK2 kinase activity. Molecular Endocrinology (Baltimore, Md.). 24: 1062-76. PMID 20304997 DOI: 10.1210/Me.2009-0355  0.574
2009 Maures TJ, Chen L, Carter-Su C. Nucleocytoplasmic shuttling of the adapter protein SH2B1beta (SH2-Bbeta) is required for nerve growth factor (NGF)-dependent neurite outgrowth and enhancement of expression of a subset of NGF-responsive genes. Molecular Endocrinology (Baltimore, Md.). 23: 1077-91. PMID 19372237 DOI: 10.1210/Me.2009-0011  0.483
2009 Robertson SA, Koleva RI, Argetsinger LS, Carter-Su C, Marto JA, Feener EP, Myers MG. Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling. Molecular and Cellular Biology. 29: 3367-78. PMID 19364823 DOI: 10.1128/Mcb.00278-09  0.56
2009 Thompson BR, Mazurkiewicz-Muñoz AM, Suttles J, Carter-Su C, Bernlohr DA. Interaction of adipocyte fatty acid-binding protein (AFABP) and JAK2: AFABP/aP2 as a regulator of JAK2 signaling. The Journal of Biological Chemistry. 284: 13473-80. PMID 19318353 DOI: 10.1074/Jbc.M900075200  0.741
2008 Jin H, Lanning NJ, Carter-Su C. JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells. Molecular Endocrinology (Baltimore, Md.). 22: 1825-41. PMID 18499741 DOI: 10.1210/Me.2008-0015  0.798
2008 Chen L, Maures TJ, Jin H, Huo JS, Rabbani SA, Schwartz J, Carter-Su C. SH2B1beta (SH2-Bbeta) enhances expression of a subset of nerve growth factor-regulated genes important for neuronal differentiation including genes encoding urokinase plasminogen activator receptor and matrix metalloproteinase 3/10. Molecular Endocrinology (Baltimore, Md.). 22: 454-76. PMID 17947375 DOI: 10.1210/Me.2007-0384  0.319
2008 Javed MJ, Tschirch E, Beattie BK, Stickle N, Huang K, Jaster R, Carter-Su C, Barber D. The SH2-B Adaptor Protein Negatively Regulates EPO-Dependent Signalling Via Interaction with Erythropoietin Receptor Ptyr-343 Blood. 112: 892-892. DOI: 10.1182/Blood.V112.11.892.892  0.403
2007 Li Z, Zhou Y, Carter-Su C, Myers MG, Rui L. SH2B1 enhances leptin signaling by both Janus kinase 2 Tyr813 phosphorylation-dependent and -independent mechanisms. Molecular Endocrinology (Baltimore, Md.). 21: 2270-81. PMID 17565041 DOI: 10.1210/Me.2007-0111  0.579
2007 Diakonova M, Helfer E, Seveau S, Swanson JA, Kocks C, Rui L, Carlier MF, Carter-Su C. Adapter protein SH2-Bbeta stimulates actin-based motility of Listeria monocytogenes in a vasodilator-stimulated phosphoprotein (VASP)-dependent fashion. Infection and Immunity. 75: 3581-93. PMID 17452473 DOI: 10.1128/Iai.00214-07  0.403
2007 Yang P, Whelan RJ, Mao Y, Lee AW, Carter-Su C, Kennedy RT. Multiplexed detection of protein-peptide interaction and inhibition using capillary electrophoresis. Analytical Chemistry. 79: 1690-5. PMID 17297974 DOI: 10.1021/Ac061936E  0.368
2007 Maures TJ, Kurzer JH, Carter-Su C. SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other. Trends in Endocrinology and Metabolism: Tem. 18: 38-45. PMID 17140804 DOI: 10.1016/J.Tem.2006.11.007  0.789
2006 Lanning NJ, Carter-Su C. Recent advances in growth hormone signaling. Reviews in Endocrine & Metabolic Disorders. 7: 225-35. PMID 17308965 DOI: 10.1007/S11154-007-9025-5  0.783
2006 Kurzer JH, Saharinen P, Silvennoinen O, Carter-Su C. Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state. Molecular and Cellular Biology. 26: 6381-94. PMID 16914724 DOI: 10.1128/Mcb.00570-06  0.779
2006 Mazurkiewicz-Munoz AM, Argetsinger LS, Kouadio JL, Stensballe A, Jensen ON, Cline JM, Carter-Su C. Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor. Molecular and Cellular Biology. 26: 4052-62. PMID 16705159 DOI: 10.1128/Mcb.01591-05  0.779
2005 Yang P, Whelan RJ, Jameson EE, Kurzer JH, Argetsinger LS, Carter-Su C, Kabir A, Malik A, Kennedy RT. Capillary electrophoresis and fluorescence anisotropy for quantitative analysis of peptide-protein interactions using JAK2 and SH2-Bβ as a model system Analytical Chemistry. 77: 2482-2489. PMID 15828784 DOI: 10.1021/Ac048307U  0.681
2004 Argetsinger LS, Kouadio JL, Steen H, Stensballe A, Jensen ON, Carter-Su C. Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity. Molecular and Cellular Biology. 24: 4955-67. PMID 15143187 DOI: 10.1128/Mcb.24.11.4955-4967.2004  0.574
2004 Kurzer JH, Argetsinger LS, Zhou YJ, Kouadio JL, O'Shea JJ, Carter-Su C. Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta. Molecular and Cellular Biology. 24: 4557-70. PMID 15121872 DOI: 10.1128/Mcb.24.10.4557-4570.2004  0.77
2004 Chen L, Carter-Su C. Adapter protein SH2-B beta undergoes nucleocytoplasmic shuttling: implications for nerve growth factor induction of neuronal differentiation. Molecular and Cellular Biology. 24: 3633-47. PMID 15082760 DOI: 10.1128/Mcb.24.9.3633-3647.2004  0.357
2004 Tang H, Macpherson P, Argetsinger LS, Cieslak D, Suhr ST, Carter-Su C, Goldman D. CaM kinase II-dependent phosphorylation of myogenin contributes to activity-dependent suppression of nAChR gene expression in developing rat myotubes Cellular Signalling. 16: 551-563. PMID 14751541 DOI: 10.1016/J.Cellsig.2003.09.006  0.385
2004 Wang X, Chen L, Maures TJ, Herrington J, Carter-Su C. SH2-B is a positive regulator of nerve growth factor-mediated activation of the Akt/Forkhead pathway in PC12 cells. The Journal of Biological Chemistry. 279: 133-41. PMID 14565960 DOI: 10.1074/Jbc.M310040200  0.489
2003 O'Brien KB, Argetsinger LS, Diakonova M, Carter-Su C. YXXL motifs in SH2-Bbeta are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling. The Journal of Biological Chemistry. 278: 11970-8. PMID 12551917 DOI: 10.1074/Jbc.M210765200  0.577
2002 Diakonova M, Gunter DR, Herrington J, Carter-Su C. SH2-Bbeta is a Rac-binding protein that regulates cell motility. The Journal of Biological Chemistry. 277: 10669-77. PMID 11786545 DOI: 10.1074/Jbc.M111138200  0.536
2002 O'Brien KB, O'Shea JJ, Carter-Su C. SH2-B family members differentially regulate JAK family tyrosine kinases. The Journal of Biological Chemistry. 277: 8673-81. PMID 11751854 DOI: 10.1074/Jbc.M109165200  0.423
2001 Herrington J, Carter-Su C. Signaling pathways activated by the growth hormone receptor. Trends in Endocrinology and Metabolism: Tem. 12: 252-7. PMID 11445442 DOI: 10.1016/S1043-2760(01)00423-4  0.492
2000 Carter-Su C, Rui L, Stofega MR, Mayo K. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone Recent Progress in Hormone Research. 55: 293-311. PMID 11036942  0.542
2000 Stofega MR, Herrington J, Billestrup N, Carter-Su C. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B. Molecular Endocrinology (Baltimore, Md.). 14: 1338-50. PMID 10976913 DOI: 10.1210/Mend.14.9.0513  0.569
2000 Carter-Su C, Rui L, Herrington J. Role of the tyrosine kinase JAK2 in signal transduction by growth hormone. Pediatric Nephrology (Berlin, Germany). 14: 550-7. PMID 10912517 DOI: 10.1007/S004670000366  0.535
2000 Herrington J, Smit LS, Schwartz J, Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene. 19: 2585-97. PMID 10851057 DOI: 10.1038/Sj.Onc.1203526  0.48
2000 Stofega MR, Argetsinger LS, Wang H, Ullrich A, Carter-Su C. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein α Journal of Biological Chemistry. 275: 28222-28229. PMID 10842184 DOI: 10.1074/Jbc.M004238200  0.591
2000 Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P, Jove R. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. The Journal of Biological Chemistry. 275: 24935-44. PMID 10823829 DOI: 10.1074/Jbc.M002383200  0.466
2000 Herrington J, Diakonova M, Rui L, Gunter DR, Carter-Su C. SH2-B is required for growth hormone-induced actin reorganization. The Journal of Biological Chemistry. 275: 13126-33. PMID 10777618 DOI: 10.1074/Jbc.275.17.13126  0.495
2000 Rui L, Gunter DR, Herrington J, Carter-Su C. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta. Molecular and Cellular Biology. 20: 3168-77. PMID 10757801 DOI: 10.1128/Mcb.20.9.3168-3177.2000  0.5
2000 Rui L, Archer SF, Argetsinger LS, Carter-Su C. Platelet-derived growth factor and lysophosphatidic acid inhibit growth hormone binding and signaling via a protein kinase C-dependent pathway Journal of Biological Chemistry. 275: 2885-2892. PMID 10644756 DOI: 10.1074/Jbc.275.4.2885  0.573
1999 Rui L, Herrington J, Carter-Su C. SH2-B, a membrane-associated adapter, is phosphorylated on multiple serines/threonines in response to nerve growth factor by kinases within the MEK/ERK cascade. The Journal of Biological Chemistry. 274: 26485-92. PMID 10473609 DOI: 10.1074/Jbc.274.37.26485  0.48
1999 Rui L, Carter-Su C. Identification of SH2-Bβ as a potent cytoplasmic activator of the tyrosine kinase janus kinase 2 Proceedings of the National Academy of Sciences of the United States of America. 96: 7172-7177. PMID 10377387 DOI: 10.1073/Pnas.96.13.7172  0.6
1999 Rui L, Herrington J, Carter-Su C. SH2-B is required for nerve growth factor-induced neuronal differentiation. The Journal of Biological Chemistry. 274: 10590-4. PMID 10187854 DOI: 10.1074/Jbc.274.15.10590  0.454
1999 Herrington J, Rui L, Luo G, Yu-Lee LY, Carter-Su C. A functional DNA binding domain is required for growth hormone-induced nuclear accumulation of Stat5B. The Journal of Biological Chemistry. 274: 5138-45. PMID 9988763 DOI: 10.1074/Jbc.274.8.5138  0.452
1998 Galigniana MD, Scruggs JL, Herrington J, Welsh MJ, Carter-Su C, Housley PR, Pratt WB. Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Molecular Endocrinology (Baltimore, Md.). 12: 1903-13. PMID 9849964 DOI: 10.1210/Mend.12.12.0204  0.382
1998 Hodge C, Liao J, Stofega M, Guan K, Carter-Su C, Schwartz J. Growth hormone stimulates phosphorylation and activation of Elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2 Journal of Biological Chemistry. 273: 31327-31336. PMID 9813041 DOI: 10.1074/Jbc.273.47.31327  0.542
1998 Carter-Su C, Smit LS. Signaling via JAK Tyrosine Kinases: Growth Hormone Receptor as a Model System Recent Progress in Hormone Research. 53: 61-82. PMID 9769703  0.466
1998 Rui L, Carter-Su C. Platelet-derived growth factor (PDGF) stimulates the association of SH2- Bβ with PDGF receptor and phosphorylation of SH2-Bβ Journal of Biological Chemistry. 273: 21239-21245. PMID 9694882 DOI: 10.1074/Jbc.273.33.21239  0.563
1998 Gong TWL, Meyer DJ, Liao J, Hodge CL, Campbell GS, Wang X, Billestrup N, Carter-Su C, Schwartz J. Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors Endocrinology. 139: 1863-1871. PMID 9528972 DOI: 10.1210/Endo.139.4.5893  0.469
1998 Stofega MR, Wang H, Ullrich A, Carter-Su C. Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association Journal of Biological Chemistry. 273: 7112-7117. PMID 9507023 DOI: 10.1074/Jbc.273.12.7112  0.585
1998 Carter-Su C. Growth hormone signal transduction Growth Hormone & Igf Research. 8: 311. DOI: 10.1016/S1096-6374(98)80130-5  0.347
1997 Rui L, Mathews LS, Hotta K, Gustafson TA, Carter-Su C. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Molecular and Cellular Biology. 17: 6633-44. PMID 9343427 DOI: 10.1128/Mcb.17.11.6633  0.591
1997 Vanderkuur JA, Butch ER, Waters SB, Pessin JE, Guan KL, Carter-Su C. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation Endocrinology. 138: 4301-4307. PMID 9322943 DOI: 10.1210/Endo.138.10.5453  0.63
1997 Smit LS, Vanderkuur JA, Stimage A, Han Y, Luo G, Yu-Lee LY, Schwartz J, Carter-Su C. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B Endocrinology. 138: 3426-3434. PMID 9231797 DOI: 10.1210/Endo.138.8.5332  0.545
1997 Campbell GS, Yu CL, Jove R, Carter-Su C. Constitutive activation of JAK1 in Src-transformed cells Journal of Biological Chemistry. 272: 2591-2594. PMID 9006890 DOI: 10.1074/Jbc.272.5.2591  0.449
1996 Carter-Su C, King AP, Argetsinger LS, Smit LS, Vanderkuur J, Campbell GS. Signalling pathway of GH. Endocrine Journal. 43: S65-70. PMID 9076344 DOI: 10.1507/Endocrj.43.Suppl_S65  0.564
1996 Argetsinger LS, Norstedt G, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon-γ, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling Journal of Biological Chemistry. 271: 29415-29421. PMID 8910607 DOI: 10.1074/Jbc.271.46.29415  0.556
1996 Dabrowski A, VanderKuur JA, Carter-Su C, Williams JA. Cholecystokinin stimulates formation of Shc-Grb2 complex in rat pancreatic acinar cells through a protein kinase C-dependent mechanism Journal of Biological Chemistry. 271: 27125-27129. PMID 8900204 DOI: 10.1074/Jbc.271.43.27125  0.528
1996 Argetsinger LS, Carter-Su C. Mechanism of signaling by growth hormone receptor Physiological Reviews. 76: 1089-1107. PMID 8874495 DOI: 10.1152/Physrev.1996.76.4.1089  0.55
1996 Carter-Su C, Schwartz J, Smit LS. Molecular mechanism of growth hormone action Annual Review of Physiology. 58: 187-207. PMID 8815791 DOI: 10.2527/Animalsci1997.75Supplement_21X  0.546
1996 Argetsinger LS, Carter-Su C. Growth hormone signalling mechanisms: Involvement of the tyrosine kinase JAK2 Hormone Research. 45: 22-24. PMID 8805024  0.417
1996 Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J, Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH Molecular Endocrinology. 10: 519-533. PMID 8732683 DOI: 10.1210/Mend.10.5.8732683  0.583
1996 King AP, Tseng MJ, Logsdon CD, Billestrup N, Carter-Su C. Distinct cytoplasmic domains of the growth hormone receptor are required for glucocorticoid- and phorbol ester-induced decreases in growth hormone (GH) binding. These domains are different from that reported for GH-induced receptor internalization. The Journal of Biological Chemistry. 271: 18088-94. PMID 8663346 DOI: 10.1074/Jbc.271.30.18088  0.451
1996 Stancato LF, David M, Carter-Su C, Larner AC, Pratt WB. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation Journal of Biological Chemistry. 271: 4134-4137. PMID 8626752 DOI: 10.1074/Jbc.271.8.4134  0.466
1995 Campbell GS, Meyer DJ, Raz R, Levy DE, Schwartz J, Carter-Su C. Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone Journal of Biological Chemistry. 270: 3974-3979. PMID 7876144 DOI: 10.1074/Jbc.270.8.3974  0.49
1995 Argetsinger LS, Hsu GW, Myers MG, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. The Journal of Biological Chemistry. 270: 14685-92. PMID 7782332 DOI: 10.1074/Jbc.270.24.14685  0.57
1995 King AP, Carter-Su C. Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts. Endocrinology. 136: 4796-803. PMID 7588209 DOI: 10.1210/Endo.136.11.7588209  0.521
1995 VanderKuur JA, Wang X, Zhang L, Allevato G, Billestrup N, Carter-Su C. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor Journal of Biological Chemistry. 270: 21738-21744. PMID 7545168 DOI: 10.1074/Jbc.270.37.21738  0.57
1995 Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science (New York, N.Y.). 269: 81-3. PMID 7541555 DOI: 10.1126/Science.7541555  0.516
1995 VanderKuur J, Allevato G, Billestrup N, Norstedt G, Carter-Su C. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2 Journal of Biological Chemistry. 270: 7587-7593. PMID 7535773 DOI: 10.1074/Jbc.270.13.7587  0.596
1994 VanderKuuri JA, Wang X, Zhang L, Campbell GS, Allevato G, Billestrup N, Norstedt G, Carter-Su C. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase Journal of Biological Chemistry. 269: 21709-21717. PMID 8063815  0.454
1994 Carter-Su C, Argetsinger LS, Campbell GS, Wang X, Ihle J, Witthuhn B. The identification of JAK2 tyrosine kinase as a signaling molecule for growth hormone Proceedings of the Society For Experimental Biology and Medicine. 206: 210-215. PMID 7517045 DOI: 10.3181/00379727-206-43744  0.562
1994 Campbell GS, Argetsinger LS, Ihle JN, Kelly PA, Rillema JA, Carter-Su C. Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants Proceedings of the National Academy of Sciences of the United States of America. 91: 5232-5236. PMID 7515493 DOI: 10.1073/Pnas.91.12.5232  0.518
1994 Meyer DJ, Campbell GS, Cochran BH, Argetsinger LS, Larner AC, Finbloom DS, Carter-Su C, Schwartz J. Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor. The Journal of Biological Chemistry. 269: 4701-4. PMID 7508925  0.443
1993 Wang X, Möller C, Norstedt G, Carter-Su C. Growth hormone-promoted tyrosyl phosphorylation of a 121-kDa growth hormone receptor-associated protein Journal of Biological Chemistry. 268: 3573-3579. PMID 8429033  0.375
1993 Campbell GS, Christian LJ, Carter-Su C. Evidence for involvement of the growth hormone receptor-associated tyrosine kinase in actions of growth hormone Journal of Biological Chemistry. 268: 7427-7434. PMID 8385106  0.472
1993 Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase Cell. 74: 237-244. PMID 8343952 DOI: 10.1016/0092-8674(93)90415-M  0.543
1993 Carter-Su C, Wang X, Campbell GS, Argetsinger LS, Billestrup N, Norstedt G, Meyer D, Schwartz J. MOLECULAR BASIS OF GROWTH HORMONE ACTION Pediatric Research. 33: S8-S8. DOI: 10.1203/00006450-199305001-00035  0.589
1992 Rillema JA, Campbell GS, Lawson DM, Carter-Su C. Evidence for a rapid stimulation of tyrosine kinase activity by prolactin in Nb2 rat lymphoma cells Endocrinology. 131: 973-975. PMID 1639035 DOI: 10.1210/en.131.2.973  0.445
1992 Stred SE, Stubbart JR, Argetsinger LS, Smith WC, Shafer JA, Talamantes F, Carter-Su C. Stimulation by growth hormone (GH) of GH receptor-associated tyrosine kinase activity. Endocrinology. 130: 1626-36. PMID 1537311 DOI: 10.1210/Endo.130.3.1537311  0.544
1992 Wang X, Uhler MD, Billestrup N, Norstedt G, Talamantes F, Nielsen JH, Carter-Su C. Evidence for association of the cloned liver growth hormone receptor with a tyrosine kinase Journal of Biological Chemistry. 267: 17390-17396. PMID 1380961  0.342
1992 Campbell GS, Pang L, Miyasaka T, Saltiel AR, Carter-Su C. Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts Journal of Biological Chemistry. 267: 6074-6080. PMID 1313428  0.449
1991 Sinha MK, Raineri-Maldonado C, Buchanan C, Pories WJ, Carter-Su C, Pilch PF, Caro JF. Adipose tissue glucose transporters in NIDDM: Decreased levels of muscle/fat isoform Diabetes. 40: 472-477. PMID 2010047 DOI: 10.2337/Diab.40.4.472  0.546
1991 Stubbart JR, Barton DF, Tai PK, Stred SE, Gorin E, Goodman HM, Carter-Su C. Antibodies to cytoplasmic sequences of cloned liver growth hormone (GH) receptors recognize GH receptors associated with tyrosine kinase activity. Endocrinology. 129: 1659-70. PMID 1874195 DOI: 10.1210/Endo-129-3-1659  0.447
1990 Stred SE, Stubbart JR, Argetsinger LS, Shafer JA, Carter-Su C. Demonstration of Growth Hormone (GH) receptor-associated tyrosine kinase activity in multiple GH-responsive cell types Endocrinology. 127: 2506-2516. PMID 2171917 DOI: 10.1210/Endo-127-5-2506  0.485
1989 Carter-Su C, Stubbart JR, Wang X, Stred SE, Argetsinger LS, Shafer JA. Phosphorylation of highly purified growth hormone receptors by a growth hormone receptor-associated tyrosine kinase Journal of Biological Chemistry. 264: 18654-18661. PMID 2478547  0.377
1988 Schwartz J, Carter-Su C. Effects of growth hormone on glucose metabolism and glucose transport in 3T3-F442A cells: Dependence on cell differentiation Endocrinology. 122: 2247-2256. PMID 3359981 DOI: 10.1210/Endo-122-5-2247  0.325
1988 Foster CM, Shafer JA, Rozsa FW, Wang X, Lewis SD, Renken DA, Natale JE, Schwartz J, Carter-Su C. Growth hormone promoted tyrosyl phosphorylation of growth hormone receptors in murine 3T3-F442A fibroblasts and adipocytes Biochemistry. 27: 326-334. PMID 3349036 DOI: 10.1021/Bi00401A049  0.473
1987 Schwartz J, Carter-Su C. Growth hormone receptor structure in adipocytes from normal and growth hormone-deficient rats Hormone and Metabolic Research. 19: 242-248. PMID 3623413 DOI: 10.1055/S-2007-1011790  0.334
1982 Pessin JE, Tillotson LG, Yamada K, Gitomer W, Carter-Su C, Mora R, Isselbacher KJ, Czech MP. Identification of the stereospecific hexose transporter from starved and fed chicken embryo fibroblasts Proceedings of the National Academy of Sciences of the United States of America. 79: 2286-2290. PMID 6954540 DOI: 10.1073/Pnas.79.7.2286  0.599
1981 Carter-Su C, Pilch PF, Czech MP. Chromatographic resolution of insulin receptor from insulin-sensitive D-glucose transporter of adipocyte plasma membranes Biochemistry. 20: 216-221. PMID 7008832 DOI: 10.1021/Bi00504A036  0.681
1980 Carter-Su C, Pillion DJ, Czech MP. Reconstituted D-glucose transport from the adipocyte plasma membrane. Chromatographic resolution of transport activity from membrane glycoproteins using immobilized concanavalin A Biochemistry. 19: 2374-2385. PMID 7387979 DOI: 10.1021/Bi00552A015  0.548
1980 Carter-Su C, Czech MP. Retention of insulin-stimulated D-glucose transport by detergent-solubilized adipocyte plasma membrane proteins reconstituted into phospholipid vesicles Annals of the New York Academy of Sciences. 332-333. PMID 7011149 DOI: 10.1111/J.1749-6632.1980.Tb15407.X  0.493
1980 Czech MP, Massague J, Pilch PF, Carter-Su C. Structural features of the insulin effector system: Relation to hexose transport activation Annals of the New York Academy of Sciences. 282-291. PMID 7011146 DOI: 10.1111/J.1749-6632.1980.Tb15401.X  0.682
1980 Pillion DJ, Carter-Su CA, Pilch PF, Czech MP. Isolation of adipocyte plasma membrane antigens by immunoaffinity chromatography. Insulinomimetic antibodies do not bind directly to the insulin receptor or the glucose transport system Journal of Biological Chemistry. 255: 9168-9176. PMID 6773960  0.553
1980 Carter-Su C, Pilch PF, Czech MP. Chromatographic resolution of the adipocyte high affinity insulin receptor from the insulin sensitive D-glucose transporter Journal of Supramolecular and Cellular Biochemistry. 12.  0.521
Show low-probability matches.